C. P. Thakkar&Company(Pharma) Ltd
C. P. Thakkar&Company(Pharma) Ltd
Maharashtra, India

COMPANY OVERVIEW

Company Album

Basic Information
C. P. Thakkar& company(pharma) limited is a closely held public limited company having an annual turnover of inr 25 crores. The company was established in year 1910 under the name and style c. P. Thakkar& company, which was later converted into a public limited company in the year 1994.The company having an experience of over 95 years in the field of pharmaceuticals is considered to be a pioneer in promotion of generics medicines market in india. C. P. Thakkar& company(pharma) limited at present is a top generics medicines distributors in india for top multinational companies like ranbaxy laboratories limited, cadila pharmaceuticals limited and wockhardt limited.With constant efforts, dedication and future vision of our enterprising directors, c. P. Thakkar& company(pharma) limited has diversified into pharmaceuticals formulations business of their own. C. P. Thakkar& company(pharma) limited has manufacturing facilities with formulators adhering to tough ISO 9002, gmp and who gmp standards.Striving hard to reach newer heights in business, c. P. Thakkar& company(pharma) limited is constantly exploring new markets in other countries.
  • Transactions
    -
Business type
Manufacturer
Country / Region
Maharashtra, India
Main ProductsTotal employees
51 - 100 People
Total Annual Revenue
US$10 Million - US$50 Million
Year established
1904
Certifications
-
Product Certifications
-
Patents
-
Trademarks
-
Main Markets

PRODUCT CAPACITY

Factory Information

Contract Manufacturing
OEM Service Offered

R&D CAPACITY

Research & Development

11 - 20 People

TRADE CAPABILITIES

Main Markets & Product(s)

Main markets
Total Revenue(%)
Main Product(s)
Verified
North America
11.11%
South America
11.11%
Western Europe
11.11%
Eastern Europe
11.11%
Eastern Asia
11.11%
Southeast Asia
11.11%
Mid East
11.11%
Africa
11.11%
Oceania
11.11%
Verified

Trade Ability

Total Annual Revenue
US$10 Million - US$50 Million